Applying antisense oligonucleotide technology to target coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.
Anders Naar
BEGIN Berkeley Gateway to Innovation portal to the UC Berkeley entrepreneurship community
Accessibility | Nondiscrimination | Privacy